Health benefits of functional foods;Fonksiyonel besinlerin saǧliǧimiz üzerine etkileri

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 48, Issue 1, 2005, Pages 69-84

  Coşkun, Turgay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Conjugated linoleic acid; Flavonoids; Functional foods; Health; Nutraceuticals; Omega 3 fatty acids; Phytochemicals; Phytoestrogens; Phytosterols; Polyphenols; Prebiotics; Probiotics; Synbiotics

Indexed keywords

LYCOPENE; OMEGA 3 FATTY ACID; PHYTOESTROGEN; TRACE ELEMENT;

ARTICLE; ATTENTION; AWARENESS; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; DAIRY PRODUCT; DIET; EATING; EYE; FISH; FOOD COMPOSITION; FOOD INTAKE; FRUIT; FUNCTIONAL FOOD; GASTROINTESTINAL TRACT; GENERAL CONDITION IMPROVEMENT; GENETIC ENGINEERING; GRAIN; HUMAN; MACRONUTRIENT; MEAT; MEDICAL ASSESSMENT; METABOLIC REGULATION; NUTRITIONAL HEALTH; OSTEOPOROSIS; SALMON; SCIENCE; TOMATO; VEGETABLE; WELLBEING;

EID: 17844385536     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (141)

1. Position of the American Dietetic Association: phytochemicals and functional foods. J Am Diet Assoc 1995; 95: 493-496.
2. Position of the American Dietetic Association: functional foods. J Am Diet Assoc 2004; 104: 814-826.
3. Haschke F, Firmansyah A, Meng M, Steenhout P, Carriè A-L. Monatsschr Kinderheilkd 2001; 149 (Suppl): S66-S70.
4. Functional foods: nutrition therapy for tomorrow? http://www. thelondonfreepress.com/HealthDOC/nutrition_article-dec.html
5. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996; 96: 1027-1039.
6. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 2003; 78(Suppl): 517S-520S.
7. Hasler CM. Functional foods: benefits, concerns and challenges - a position paper from the American Council on Science and Health. J Nutr 2002; 132: 3772-3781.
8. Isolauri E, Ribeiro Hda C, Gibson G, et al. Functional foods and probiotics: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2002; 35 (Suppl): S106-109.
9. Jones PJ. Clinical nutrition: 7. Functional foods - more than just nutrition. CMAJ 2002; 166: 1555-1563.
10. Charalampopoulos D, Wang R, Pandiella SS, Webb C. Application of cereals and cereal components in functional foods: a review. Int J Food Microbiol 2002; 79: 131-141.
11. What you need to know about new food words - phytochemicals, functional foods, and nutraceuticals. http://www.extension.iastate.edu/Publications/PM1846. pdf
12. An introduction to functional foods, nutraceuticals and natural health products. http://www.sbrc.ca/ncarm/introfuncfoods.htm
13. Hasler CM. The cardiovascular effects of soy products. J Cardiovasc Nurs 2002; 16: 50-63.
14. Farr DR. Functional foods. Cancer Letters 1997; 114: 59-63.
15. Kwak No-S, Jukes DJ. Fuctional foods. Part 1: the development of a regulatory concept. Food Control 2001; 12: 99-107.
16. Korver O. 'Healthy' developments in the food industry. Cancer Lett 1997; 114: 19-23.
17. Questions and answers about functional foods. http://ific.org/ publications/qa/funcfdsqa.cfm?renderforprint=1
18. Hardy G, Hardy I, Ball PA. Nutraceuticals - a pharmaceutical viewpoint: part II. Curr Opin Clin Nutr Metab Care 2003; 6: 661-671.
19. Dillard CJ, German JB. Phytochemicals: nutraceuticals and human health. J Sci Food Agric 2000; 80: 1744-1756.
20. Reid G. The role of cranberry and probiotics in intestinal and urogenital tract health. Crit Rev Food Sci Nutr 2002; 42 (Suppl): 293-300.
21. Biesalski HK. Nutraceuticals: the link between nutrititon and medicine. J Toxicol - Cut & Ocular Toxicol 2002; 21: 9-30.
22. Heller IR, Siverglade B. Functional foods. Health boon or quackery? Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz 2001; 44: 214-218.
23. Prior RL. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 2003; 78(Suppl): 570S-578S.
24. Nishino H, Murakoshi M, Ii T, et al. Carotenoids in cancer chemoprevention. Cancer Metastasis Rev 2002; 21: 257-264.
25. Bouic PJ. The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years. Curr Opin Clin Nutr Metab Care 2001; 4: 471-475.
26. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78(Suppl): 559S-569S.
27. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
28. Muller N, Alteheld B, Stehle P. Tomato products and lycopene supplements: mandatory components in nutritional treatment of cancer patients? Curr Opin Clin Nutr Metab Care 2003; 6: 657-660.
29. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19-34.
30. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst 2001; 93: 1872-1879.
31. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC.A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 2002; 94: 391-398.
32. Barratt-Fornell A, Drewnowski A. The taste of health: nature's bitter gifts. Nutrition Today 2002; 37: 144-150.
33. Crowell PL. Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat 1997; 46: 191-197.
34. What you need to know about the health benefits of functional foods. http://www.extension.iastate.edu/Publications/PM1798.pdf
35. 'Functional foods' confer specific health benefits. http://cfapps. naplesnews.com/sendlink/printthis.cfm
36. Kardinaal AF, Waalkens-Berendsen DH, Arts CJ. Pseudo-estrogens in the diet: health benefits and safety concerns. Trends Food Sci Technol 1997; 8: 327-333.
37. Rickard SE, Yuan YV, Chen J, Thompson LU. Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 1999; 35: 50-57.
38. Takezaki T, Gao CM, Ding JH, Liu TK, Li MS, Tajima K. Comparative study of lifestyles of residents in high and low risk areas for gastric cancer in Jiangsu Province, China, with special reference to allium vegetables. J Epidemiol 1999; 9: 297-305.
39. Canizares P, Gracia I, Gomez LA, et al. Allylthiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog 2004; 20: 397-401.
40. Durak I, Kavutcu M, Aytac B, et al. Effects of garlic extract consumption on blood lipid and oxidant/ antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem 2004; 15: 373-377.
41. Reilly C. Selenium: a new entrant into the functional food arena. Trends Food Sci Technol 1998; 9: 114-118.
42. Neve J. Selenium as 'nutraceutical': how to conciliate physiological and supra- nutritional effects for an essential trace element. Curr Opin Clin Nutr Metab Care 2002; 5: 659-663.
43. Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003; 133: 3248S-3254S.
44. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997; 146: 223-230.
45. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000; 92: 154-160.
46. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res 2003; 17: 845-869.
47. Soy and human health. http://www.myhealthdriver.com/soy/
48. Centre de Recherche et d'Information Nutritionnelles. Special issue "functional foods": health benefits and safety issues. CLA no 2 CLA. http://www.cerin.org/periodiques/ CLA/CLA_7_2.asp
49. Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003; 78(Suppl): 593S-609S.
50. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet 1991; 337: 1197-1200.
51. Wu AH, Ziegler RG, Nomura AM, et al. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr 1998; 68(Suppl): 1437S-1443S.
52. Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health. Crit Rev Food Sci Nutr 2002; 42(Suppl): 301-316.
53. Wylie-Rosett J, Mossavar-Rahmani Y, Gans K. Recent dietary guidelines to prevent and treat cardiovascular disease, diabetes, and obesity. Heart Disease 2002; 4: 220-230.
54. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
55. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 1996; 312: 478-481.
56. Pelletier S, Kundrat S, Hasler CM. Effects of a functional foods nutrition education program with cardiac rehabilitation patients. J Cardiopulmonary Rehab 2003; 23: 334-340.
57. Ostlund RE. Phytosterols in human nutrition. Annu Rev Nutr 2002; 22: 533-549.
58. Trautwein EA, Duchateau GS, Lin Y, Mel'nikov SM, Molhuizen HO, Ntanios FY. Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur J Lipid Sci Technol 2003; 105: 171-185.
59. Brown AJ. Atherosclerosis: cell biology and lipoproteins: cholesterol absorption inhibitors: gateway therapy for hypercholesterolaemia. Curr Opin Lipidol 2002; 13: 701-703.
60. Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130: 53-56.
61. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 1997; 8: 645-649.
62. Meister KA, Whelan EM, Kava R. The health effects of moderate alcohol intake in humans: an epidemiologic review. Crit Rev Clin Lab Sci 2000; 37: 261-96.
63. Yang CS, Landau JM. Effects of tea consumption on nutrition and health. J Nutr 2000; 130: 2409-2412.
64. Davies MJ, Judd JT, Baer DJ, et al. Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 2003; 133: 3298S-3302S.
65. Ioannides C, Yoxall V. Antimutagenic activity of tea: role of polyphenols. Curr Opin Clin Nutr Metab Care 2003; 6: 649-656.
66. Bruinsma K, Taren DL. Chocolate: food or drug? J Am Diet Assoc 1999; 99: 1249-1256.
67. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 2001; 74: 596-602.
68. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-1420.
69. Mozaffarieh M, Sacu S, Wedrich A. The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J 2003; 2: 20-28.
70. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 2001; 103: 258-262.
71. Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment. Br Med J 2004; 328: 30-35.
72. Rennie KL, Hughes J, Lang R, Jebb SA. Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet 2003; 16: 97-109.
73. Holub BJ. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. CMAJ 2002; 166: 608-615.
74. Krauss RM, Eckel RH, Howard B, et al. AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000; 102: 2284-2299.
75. Lee KW, Lip GY. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM 2003; 96: 465-480.
76. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002; 112: 298-304.
77. Kehn P, Fernandes G. The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases. J Clin Immunol 2001; 21: 99-101.
78. Friedland RP. Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch Neurol 2003; 60: 923-924.
79. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940-946.
80. Freeman MP. Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 2000; 12: 159-165.
81. Akisu M, Baka M, Coker I, Kultursay N, Huseyinov A. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice, n-3 fatty acids alter platelet-activating factor and leukotriene B4 production in the intestine. Biol Neonate 1998; 74: 31-38.
82. Akisu M, Huseyinov A, Baka M, Yalaz M, Kultursay N. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet- activating factor and leukotriene B4 in hypoxicischemic brain in young mice. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 429-433.
83. Kaput J. Diet-disease gene interactions. Nutrition 2004; 20: 26-31.
84. Labadarios D, Meguid MM. Nutrigenomics: unraveling man's constitution in relation to food. Nutrition 2004; 20: 2-3.
85. Ordovas JM, Mooser V. Nutrigenomics and nutrigenetics. Curr Opin Lipidol 2004; 15: 101-108.
86. Olson RE. Nutrition and genetics: an expanding frontier. Am J Clin Nutr 2003; 78: 201-208.
87. Rainer L, Heiss CJ. Conjugated linoleic acid: health implications and effects on body composition. J Am Diet Assoc 2004; 104: 963-968.
88. Belury MA. Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Nutr Rev 1995; 53(4 Pt 1): 83-89.
89. Belury MA. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 2002; 132: 2995-2998.
90. Functional foods and nutraceuticals. http://www.consumermanitoba.ca/ newsletter_preview.html
91. Bengmark S. Pre-, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 2001; 4: 571-579.
92. Van Loo JA. Prebiotics promote good health: the basis, the potential, and the emerging evidence. J Clin Gastroenterol 2004; 38(Suppl): S70-75.
93. Manning TS, Gibson GR. Microbial-gut interactions in health and disease. Prebiotics. Best Pract Res Clin Gastroenterol 2004; 18: 287-298.
94. Lidestri M, Agosti M, Marini A, Boehm G. Oligosaccharides might stimulate calcium absorption in formula-fed preterm infants. Acta Paediatr Suppl 2003; 91: 91-92.
95. Morohashi T, Sano T, Ohta A, Yamada S. True calcium absorption in the intestine is enhanced by fructooligosaccharide feeding in rats. J Nutr 1998; 128: 1815-1818.
96. Marini A, Negretti F, Boehm G, et al. Pro- and prebiotics administration in preterm infants: colonization and influence on faecal flora. Acta Paediatr Suppl 2003; 91: 80-81.
97. Moro GE, Mosca F, Miniello V, et al. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr Suppl 2003; 91: 77-79.
98. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 2004; 38(Suppl): S80-83.
99. Isolauri E. The role of probiotics in paediatrics. Curr Pediatr 2004; 14: 104-109.
100. Markowitz JE, Bengmark S. Probiotics in health and disease in the pediatric patient. Pediatr Clin North Am 2002; 49: 127-141.
101. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003; 17: 277-283.
102. Elmer GW. Probiotics: "living drugs". Am J Health Syst Pharm 2001; 58: 1101-1109.
103. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-519.
104. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003; 91: 48-55.
105. Amital H, Gilburd B, Shoenfeld Y. Intelligent nutrition: health-promoting mechanisms of probiotics. Isr Med Assoc J 2003; 5: 812-813.
106. Otles S, Cagindi O, Akcicek E. Probiotics and health. Asian Pac J Cancer Prev 2003; 4: 369-372.
107. Ouwehand A, Vesterlund S. Health aspects of probiotics. I Drugs 2003; 6: 573-580.
108. Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002; 41(Suppl)1: 132-37.
109. Vanderhoof JA, Young RJ. Probiotics in pediatrics. Pediatrics 2002; 109: 956-958.
110. Bengmark S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract Res Clin Gastroenterol 2003; 17: 833-848.
111. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001; 101: 229-238.
112. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002; 82: 279-289.
113. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16: 658-672.
114. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 678-684.
115. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004; 7: 59-62.
116. Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 2003; 17: 775-783.
117. Wullt M, Hagslatt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003; 35: 365-367.
118. Felley C, Michetti P. Probiotics and Helicobacter pylori. Best Pract Res Clin Gastroenterol 2003; 17: 785-791.
119. Goossens D, Jonkers D, Stobberingh E, van den Bogaard A, Russel M, Stockbrugger R. Probiotics in gastroenterology: indications and future perspectives. Scand J Gastroenterol 2003;(Suppl):15-23.
120. Sgouras D, Maragkoudakis P, Petraki K, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 2004; 70: 518-526.
121. Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrobial Agents 2003; 22: 360-366.
122. Burger O, Weiss E, Sharon N, Tabak M, Neeman I, Ofek I. Inhibition of Helicobacter pylori adhesion to human gastric mucus by a high-molecular-weight constituent of cranberry juice. Crit Rev Food Sci Nutr 2002; 42(Suppl): 279-284.
123. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 189: 1202-1208.
124. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001; 73(Suppl): 437S-443S.
125. Reid G. Probiotics for urogenital health. Nutr Clin Care 2002; 5: 3-8.
126. Reid G. The potential role of probiotics in pediatric urology. J Urol 2002; 168(4 Pt 1): 1512-1517.
127. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by orally administered Lactobacillus rhamnosus GG. Isr Med Assoc J 2003; 5: 767-769.
128. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36: 223-227.
129. Laiho K, Ouwehand A, Salminen S, Isolauri E. Inventing probiotic functional foods for patients with allergic disease. Ann Allergy Asthma Immunol 2002; 89(Suppl): 75-82.
130. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract Res Clin Gastroenterol 2003; 17: 725-740.
131. Rafter J. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol 2003; 17: 849-859.
132. Xiao JZ, Kondo S, Takahashi N, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 2003; 86: 2452-2461.
133. Pereira DI, McCartney AL, Gibson GR. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Appl Environ Microbiol 2003; 69: 4743-4752.
134. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr 2002; 76: 1249-1255.
135. Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003; 17: 655-659.
136. Gionchetti P, Amadini C, Rizzello F, Venturi A, Poggioli G, Campieri M. Probiotics for the treatment of postoperative complications following intestinal surgery. Best Pract Res Clin Gastroenterol 2003; 17: 821-831.
137. Veereman-Wauters G. Pouchitis prevention with probiotics. J Pediatr Gastroenterol Nutr 2003; 37: 636.
138. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004; 38(Suppl): S104-106.
139. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-1633.
140. Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 2003; 17: 805-820.
141. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004; 79: 261-267.